Rogaratinib in patients with advanced urothelial carcinomas selected for tumor FGFR mRNA expression and impact of mutations in the FGFR signaling pathway-MedSci.cn

Rogaratinib in patients with advanced urothelial carcinomas selected for tumor FGFR mRNA expression and impact of mutations in the FGFR signaling pathway

Schuler, M; Cassier, P; Penel, N; Cathomas, R; Richly, H; Schostak, M; Janitzky, A; Wermke, M; Nogova, L; Tai, D; Sayehli, C; Grullich, C; Grande, E; Navarro, A; Park, SH; Nogai, H; Bender, S; Ellinghaus, P; Joerger, M

ONCOLOGY RESEARCH AND TREATMENT, 2018; 41 (): 321

科室
- - 订阅+
  - 更多科室
工具
服务